Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]
Tokito Y +10 more
europepmc +1 more source
Development and validation of the "FeiChangHeHu" WeChat mini-program for real-time management of chemotherapy-induced nausea and vomiting in lung cancer patients. [PDF]
Zeng F, Li Q, Li J, Xiao X.
europepmc +1 more source
Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial. [PDF]
Liu X +7 more
europepmc +1 more source
Optimizing Antiemetic Strategies Across Phases of Chemotherapy-Induced Nausea and Vomiting: Real-World Evidence in Breast Cancer. [PDF]
Doğan A +4 more
europepmc +1 more source
Effective Use of Olanzapine for Chemotherapy-Induced Nausea and Vomiting in a Patient Receiving Dose-Adjusted Rituximab, Etoposide, Prednisone, Vincristine (Oncovin®), Cyclophosphamide, and Doxorubicin (R-EPOCH): A Case Report. [PDF]
Shimada H +4 more
europepmc +1 more source
Netupitant/palonosetron is effective for preventing chemotherapy-induced nausea and vomiting in high-dose melphalan conditioning before autologous stem cell transplantation: A real-world analysis. [PDF]
Cao LQ +15 more
europepmc +1 more source
Acupuncture for nausea and vomiting induced by highly emetogenic chemotherapy: a systematic review and meta-analysis. [PDF]
Lin R +8 more
europepmc +1 more source
Editorial: Recent advances in translational neurovascular and cerebroprotection research. [PDF]
Boltze J +4 more
europepmc +1 more source
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine. [PDF]
Higuchi A +13 more
europepmc +1 more source
A randomized, controlled, multicenter phase III clinical trial of Huo Xiang Zheng Qi oral liquid for the prevention and control of nausea and vomiting caused by multiday cisplatin-based regimen. [PDF]
Tong L +17 more
europepmc +1 more source

